Jonathan Porter, former Chief Product Officer, has been promoted to Chief Executive Officer of the company. With the ...

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Compass Therapeutics, Inc. (NASDAQ:CMPX) stands against other hot biotech stocks ...

This investment not only strengthens our capital structure but also enriches our strategic capabilities ... 298380), a clinical-stage biotech company developing bispecific antibody technology for ...

and bispecific antibodies for cancer. Boshoff will retain overall responsibility for Pfizer's dedicated oncology R&D operation, whose structure will remain unchanged from what was announced ...

Some cancer immunotherapies consist of antibodies ... of the multimeric structure and extraordinary antigen sensitivity of natural T cell receptors (TCRs) to engineer bispecific chimeric TCRs ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Traditional ADC development requires a lot of iterative testing of antibodies, nanobodies, any kind of maybe bispecific and ... schedule but similar cohort structure is a few months behind.

The drop in Hudson’s pay also coincided with a future-looking adjustment in the payment structure for the CEO post ... $600 million upfront buyout of Dren Bio’s clinical stage bispecific antibody. The ...